This volume comprehensively focuses on polycystic ovary, metabolic syndrome and obesity and their impact on women’s health, reproduction and quality of life from adolescence to old age.
PCOS is analyzed form the early origins - highlighting the importance of diagnosis, management and treatment starting from the high-risk period of adolescence - throughout infertility PCOS-related issues, pregnancy and menopause transition. All aspects of this syndrome are covered also in relation with endocrine and metabolic features that affects women’s health.
This book is a very useful tool for gynecologists, endocrinologists, obstetricians, reproductive medicine and general practitioners and is an important resource for all physicians involved in women’s health.
Edited by:
Andrea R. Genazzani,
Lourdes Ibáñez,
Andrzej Milewicz,
Duru Shah
Imprint: Springer Nature Switzerland AG
Country of Publication: Switzerland
Edition: 2021 ed.
Dimensions:
Height: 235mm,
Width: 155mm,
Weight: 367g
ISBN: 9783030636524
ISBN 10: 3030636526
Series: ISGE Series
Pages: 227
Publication Date: 27 October 2022
Audience:
Professional and scholarly
,
Undergraduate
Format: Paperback
Publisher's Status: Active
Chapter 1. Early Origins, Diagnosis & Treatment of Adolescent PCOS.- Chapter 2. Early Origins, Diagnosis & Treatment of PCOS in Adolescent Girls.- Chapter 3. Environment factors responsible for obesity and insuline resistance in polycystic ovary syndrome.- Chapter 4. Pathogenesis of PCOS: from metabolic and neuroendocrine implications to the choice of the therapeutic strategy.- Chapter 5. Personalized therapies: why, when and for how long, the need of tailoring.- Chapter 6. Endocrine and molecular features involved in follicular arrest of PCOS women.- Chapter 7. Quality of life and Sexual Health.- Chapter 8. Infertility Management in Lean v/s obese PCOS.- Chapter 9. Treatment of Infertility in women with PCOS.- Chapter 10. Management of PCOS women preparing pregnancy.- Chapter 11. Impact of polycystic ovarian syndrome, metabolic syndrome and obesity on women’s health.- Chapter 12. Pregnancy outcome and metabolic syndrome.- Chapter 13. PCO and pregnancy: what the physician(or obstetrician) has to know to assure the best pregnancy follow-up.- Chapter 14. The role of insulin resistance in benign breast disease.- Chapter 15. Inflammation and the metabolic syndrome during the menopausal transition.- Chapter 16. Metabolic changes at the menopausal transition.- Chaer 17. Cardiovascular impact - Cardiovascular impact of metabolic abnormalities.- Chapter 18. How to prevent, to diagnose and to treat gynecological cancer in PCO patients?.
Andrea R. GenazzaniPresident, International Society of Gynecological Endocrinology Lourdes IbáñezEndocrinology, Pediatric Research Institute, Sant Joan de Déu Children's Hospital, Barcelona, Spain Andrzej Milewicz Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland. Duru ShahDirector, Department of Gynaecology, Gynaecworld - The Centre for Women's Health and Fertility; Founder President, The PCOS Society (India), Mumbai, Maharashtra, India
